Remove tag biomarker
article thumbnail

‘Click’ chemistry used to tag proteins made by cancer cells 

Drug Discovery World

A new method to study the proteins released by cells, which could lead to new biomarkers for diseases including cancer, has been developed by scientists at the Francis Crick Institute and Imperial College London. . Biomarkers are valuable tools in diagnosing disease or predicting treatment outcomes, but they are challenging to find. .

Protein 52
article thumbnail

Grand Rounds April 14, 2023: RECOVER in Action – Status of Clinical Trial Protocols (Kanecia Zimmerman, PhD, MD, MPH)

Rethinking Clinical Trials

We have people with experience with post-viral symptoms, treating ME/CFS, general COVID knowledge, biomarker experience, clinical trials, patient-reported outcomes, and more. Learn more Visit [link] Discussion Themes – What experts are being convened for the different trials? It’s all over the place.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cancer research drugs: Where is the innovation?

Drug Discovery World

Click’ chemistry used to tag proteins made by cancer cells. A new method to study the proteins released by cells, which could lead to new biomarkers for diseases including cancer, has been developed by scientists at the Francis Crick Institute and Imperial College London. .

Drugs 52
article thumbnail

A broad range of unmet needs remains in the immuno-oncology space

Pharmaceutical Technology

IO therapies come with a hefty price tag, with ICI therapies in the US typically exceeding $100,000, while cell therapies can exceed $400,000. There were also personalised care-related unmet needs identified, and this included the need for better predictive biomarkers. Cost-related unmet needs also scored highly.

article thumbnail

Potential disease-modifying therapy for Parkinson’s disease

Drug Discovery World

Importance of healthy mitochondrial function Dysfunctional mitochondria are usually tagged for removal via mitophagy with a protein ‘flag’ called ubiquitin. It also reduced potential biomarkers of disease including phosphorylated alpha-synuclein and glial cell activation.

In-Vivo 52
article thumbnail

Roche’s Early Alzheimer’s Blood Test Gets FDA Breakthrough Device Designation

XTalks

Previously, Roche secured an FDA breakthrough tag for another one of its Alzheimer’s blood tests that detects levels of pTau-181 and ApoE4 (apolipoprotein e4). Roche says one in nine Americans over 65 have Alzheimer’s dementia, the most common form of dementia. The disease has an estimated $360 billion cost to the US economy.

article thumbnail

Biogen updates on its confirmatory Aduhelm trial

pharmaphorum

Aduhelm (aducanumab) was approved by the FDA in June, but has been held back by a glacial rollout as clinicians have questioned the data on which the decision to clear the drug was based, plus a $56,000 per year price tag, which has in turn led to pushback by payers.

Trials 52